Eton Pharmaceuticals, Inc. announced that it has entered into agreements to issue and sell 1,287,500 shares of common stock at a price of $3.50 per share for gross proceeds of $4,506,250 and to issue pre-funded warrants to purchase an aggregate of 2,462,500 shares of common stock at a price of $3.50 per share for gross proceeds of $8,618,750 for the aggregate gross proceeds of $13,125,000 on April 15, 2024. The Company also entered into an agreement to expand its existing credit facility by $21.9 million to $27.0 million and in connection therewith agreed to issue a warrant to the lender for up to 358,976 shares of common stock at a price of $3.66 per share